In vivo anti-mouse PD-1 (CD279)

In vivo anti-mouse PD-1 (CD279) is an antibody designed for research use in mouse model studies involving immune checkpoint pathways, T cell regulation, tumor immunology, inflammation, and immune response modulation. PD-1, also known as CD279, is an inhibitory receptor expressed mainly on activated T cells and other immune cells. It plays an important role in controlling immune activation, maintaining immune tolerance, and regulating T cell exhaustion.

This antibody is suitable for laboratories working with in vivo mouse immunology models, including cancer immunotherapy research, immune checkpoint studies, infection models, autoimmune disease research, and preclinical immune response evaluation.

Product Overview

Programmed cell death protein 1, commonly known as PD-1 or CD279, is a key immune checkpoint receptor involved in the regulation of T cell activity. Interaction of PD-1 with its ligands, PD-L1 and PD-L2, can reduce T cell activation, cytokine production, and immune-mediated cytotoxicity.

In vivo anti-mouse PD-1 (CD279) is used in mouse research models to study the biological role of PD-1 signaling and its impact on immune responses. It is commonly used in experimental systems where modulation of the PD-1 pathway is required to evaluate T cell function, anti-tumor immunity, immune exhaustion, and immune checkpoint biology.

Key Features

• Anti-mouse PD-1 / CD279 antibody for research use
• Suitable for in vivo mouse model studies
• Supports immune checkpoint pathway research
• Relevant for cancer immunology and tumor model studies
• Useful for T cell activation, exhaustion, and immune regulation studies
• Applicable in inflammation, infection, and autoimmune research models
• Designed for preclinical and experimental immunology applications

Applications

This In vivo anti-mouse PD-1 (CD279) antibody may be used in:

• Mouse in vivo antibody studies
• Immune checkpoint research
• Tumor immunology models
• Cancer immunotherapy research
• T cell function studies
• T cell exhaustion research
• Infection and chronic inflammation models
• Autoimmune disease research
• PD-1 / PD-L1 pathway studies
• Preclinical immune modulation experiments

Research Areas

This product is suitable for research in:

• Immunology
• Oncology
• Cancer immunotherapy
• Inflammation
• Autoimmunity
• Infectious disease models
• T cell biology
• Immune checkpoint signaling
• Translational mouse model research

Why Target PD-1 / CD279?

PD-1 is one of the most studied immune checkpoint receptors because of its central role in limiting immune responses. In tumor microenvironments and chronic immune stimulation, PD-1 signaling is often associated with reduced T cell activity and functional exhaustion.

Using an anti-mouse PD-1 antibody in experimental mouse models helps researchers investigate how PD-1 pathway modulation affects T cell responses, tumor growth, cytokine production, and immune activation.

Suggested Use

Use this antibody in mouse models where PD-1 pathway modulation is required. The appropriate dose, route of administration, schedule, and control antibody should be optimized according to the study design, disease model, and experimental objective.

For best experimental interpretation, use a suitable isotype-matched control antibody in parallel.

Product Description for SEO

In vivo anti-mouse PD-1 (CD279) is a research-use antibody for mouse in vivo studies involving immune checkpoint regulation, T cell biology, cancer immunotherapy, tumor immunology, and PD-1 / PD-L1 pathway research. It is suitable for preclinical mouse models and immune modulation experiments.

FAQ

What is In vivo Anti-mouse PD-1 (CD279) used for?

It is used in mouse research models to study PD-1 immune checkpoint signaling, T cell regulation, immune exhaustion, and anti-tumor immune responses.

What does CD279 mean?

CD279 is another name for PD-1, also called programmed cell death protein 1. It is an immune checkpoint receptor involved in the regulation of immune cell activation.

Is this antibody suitable for mouse models?

Yes, this antibody is intended for research use in mouse in vivo studies involving PD-1 pathway biology.

Can it be used in cancer immunotherapy research?

Yes, anti-mouse PD-1 antibodies are commonly used in tumor immunology and cancer immunotherapy research models to study immune checkpoint pathway modulation.

Should I use an isotype control?

Yes, an appropriate isotype control is recommended to help evaluate antibody-specific effects versus non-specific background activity.

Is this product for diagnostic or therapeutic use?

No. This product is intended for research use only.

Short Product Summary

In vivo anti-mouse PD-1 (CD279) is an anti-mouse immune checkpoint antibody for in vivo research applications. It is suitable for mouse model studies focused on PD-1 signaling, T cell regulation, tumor immunology, cancer immunotherapy, and immune response modulation.